Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: a systematic review and meta‐analysis

Abstract

Background: Diabetes is a risk factor for dementia, but we do not know whether specific diabetes medications ameliorate this risk. Objective: To systematically review and meta‐analyze such medication's effect on the risk of developing dementia, mild cognitive impairment (MCI), or cognitive decline.